Featured Products

My Quote Request

No products added yet

6505-01-280-4733

20 Products

SILVADENE CREAM

SULFADIAZINE SILVER CREAM

NSN, MFG P/N

6505012804733

NSN

6505-01-280-4733

View More Info

SILVADENE CREAM

SULFADIAZINE SILVER CREAM

NSN, MFG P/N

6505012804733

NSN

6505-01-280-4733

MFG

SANOFI-AVENTIS U.S. INC

Description

ACTIVE INGREDIENT AND STRENGTH: 1.000 SULFADIAZINE SILVER PERCENTAGE, W/W
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SULFADIAZINE SILVER CREAM 1% 85GM
PRIMARY CONTAINER CONTENT QUANTITY: 85.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE

16005

NITROGLYCERIN INJECTION,USP

NSN, MFG P/N

6505012804781

NSN

6505-01-280-4781

View More Info

16005

NITROGLYCERIN INJECTION,USP

NSN, MFG P/N

6505012804781

NSN

6505-01-280-4781

MFG

LYPHOMED INC DIV OF FUJISAWA USA INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS NITROGLYCERIN PER MILLILITER
ADMINISTRATION: INTRAVENOUS
PHARMACEUTICAL VEHICLE TYPE: PROPYLENE GLYCOL
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL

NDC00469-1600-20

NITROGLYCERIN INJECTION,USP

NSN, MFG P/N

6505012804781

NSN

6505-01-280-4781

View More Info

NDC00469-1600-20

NITROGLYCERIN INJECTION,USP

NSN, MFG P/N

6505012804781

NSN

6505-01-280-4781

MFG

LYPHOMED INC DIV OF FUJISAWA USA INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS NITROGLYCERIN PER MILLILITER
ADMINISTRATION: INTRAVENOUS
PHARMACEUTICAL VEHICLE TYPE: PROPYLENE GLYCOL
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL

NDC00517-4805-10

NITROGLYCERIN INJECTION,USP

NSN, MFG P/N

6505012804781

NSN

6505-01-280-4781

View More Info

NDC00517-4805-10

NITROGLYCERIN INJECTION,USP

NSN, MFG P/N

6505012804781

NSN

6505-01-280-4781

MFG

LUITPOLD PHARMACEUTICALS INC OSTEOHEALTH COMPANY OSTEOHEALTH DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS NITROGLYCERIN PER MILLILITER
ADMINISTRATION: INTRAVENOUS
PHARMACEUTICAL VEHICLE TYPE: PROPYLENE GLYCOL
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL

81850

LORAZEPAM TABLETS,USP

NSN, MFG P/N

6505012809924

NSN

6505-01-280-9924

View More Info

81850

LORAZEPAM TABLETS,USP

NSN, MFG P/N

6505012809924

NSN

6505-01-280-9924

MFG

GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 MILLIGRAMS LORAZEPAM ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: INDIVIDUALLY SEALED
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 TABLETS
PRIMARY CONTAINER TYPE: CARD
SPECIAL FEATURES: CONTROLLED SUBSTANCE CLASSIFICATION:SCHEDULE IV;
TOTAL PRIMARY CONTAINER QUANTITY: 10

NDC00182-1806-89

LORAZEPAM TABLETS,USP

NSN, MFG P/N

6505012809924

NSN

6505-01-280-9924

View More Info

NDC00182-1806-89

LORAZEPAM TABLETS,USP

NSN, MFG P/N

6505012809924

NSN

6505-01-280-9924

MFG

GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 MILLIGRAMS LORAZEPAM ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: INDIVIDUALLY SEALED
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 TABLETS
PRIMARY CONTAINER TYPE: CARD
SPECIAL FEATURES: CONTROLLED SUBSTANCE CLASSIFICATION:SCHEDULE IV;
TOTAL PRIMARY CONTAINER QUANTITY: 10

100-2833

DEXTROSE AND SODIUM CHLORIDE INJECTION,USP

NSN, MFG P/N

6505012811243

NSN

6505-01-281-1243

View More Info

100-2833

DEXTROSE AND SODIUM CHLORIDE INJECTION,USP

NSN, MFG P/N

6505012811243

NSN

6505-01-281-1243

MFG

SCHEIN HENRY INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,KENDALL MCGAW
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 10

NDC00264-1610-10

DEXTROSE AND SODIUM CHLORIDE INJECTION,USP

NSN, MFG P/N

6505012811243

NSN

6505-01-281-1243

View More Info

NDC00264-1610-10

DEXTROSE AND SODIUM CHLORIDE INJECTION,USP

NSN, MFG P/N

6505012811243

NSN

6505-01-281-1243

MFG

B BRAUN MEDICAL INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,KENDALL MCGAW
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 10

HESPAN

HETASTARCH IN SODIUM CHLORIDE INJECTION

NSN, MFG P/N

6505012811247

NSN

6505-01-281-1247

View More Info

HESPAN

HETASTARCH IN SODIUM CHLORIDE INJECTION

NSN, MFG P/N

6505012811247

NSN

6505-01-281-1247

MFG

BRISTOL-MYERS SQUIBB PHARMA COMPANY

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT AND 6.000 PERCENTAGE, W/V HETASTARCH ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HETASTARCH IN SODIUM CHLORIDE INJECTION 500ML BAG 12S
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG WITH HANGING DEVICE, PLASTIC
SPECIAL FEATURES: 12 OVERPOUCHES PER PACKAGE ALSO SUPPLIED TO SERVE AS A WATER VAPOR BARRIER; FOR USE WITH THE FOLLOWING NSNS' 6515-00-115-0032,6515-00-140-0888,6515-00-185-5158,6515-00-484-0484,6515-01-082-1021,6515-01-105-0614,6515-01-153-4703,AND 6515-01-153-5669
TOTAL PRIMARY CONTAINER QUANTITY: 12

NDC00056-0037-46

HETASTARCH IN SODIUM CHLORIDE INJECTION

NSN, MFG P/N

6505012811247

NSN

6505-01-281-1247

View More Info

NDC00056-0037-46

HETASTARCH IN SODIUM CHLORIDE INJECTION

NSN, MFG P/N

6505012811247

NSN

6505-01-281-1247

MFG

BRISTOL-MYERS SQUIBB PHARMA COMPANY

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT AND 6.000 PERCENTAGE, W/V HETASTARCH ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HETASTARCH IN SODIUM CHLORIDE INJECTION 500ML BAG 12S
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG WITH HANGING DEVICE, PLASTIC
SPECIAL FEATURES: 12 OVERPOUCHES PER PACKAGE ALSO SUPPLIED TO SERVE AS A WATER VAPOR BARRIER; FOR USE WITH THE FOLLOWING NSNS' 6515-00-115-0032,6515-00-140-0888,6515-00-185-5158,6515-00-484-0484,6515-01-082-1021,6515-01-105-0614,6515-01-153-4703,AND 6515-01-153-5669
TOTAL PRIMARY CONTAINER QUANTITY: 12

NDC00074-7248-03

HETASTARCH IN SODIUM CHLORIDE INJECTION

NSN, MFG P/N

6505012811247

NSN

6505-01-281-1247

View More Info

NDC00074-7248-03

HETASTARCH IN SODIUM CHLORIDE INJECTION

NSN, MFG P/N

6505012811247

NSN

6505-01-281-1247

MFG

ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT AND 6.000 PERCENTAGE, W/V HETASTARCH ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HETASTARCH IN SODIUM CHLORIDE INJECTION 500ML BAG 12S
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG WITH HANGING DEVICE, PLASTIC
SPECIAL FEATURES: 12 OVERPOUCHES PER PACKAGE ALSO SUPPLIED TO SERVE AS A WATER VAPOR BARRIER; FOR USE WITH THE FOLLOWING NSNS' 6515-00-115-0032,6515-00-140-0888,6515-00-185-5158,6515-00-484-0484,6515-01-082-1021,6515-01-105-0614,6515-01-153-4703,AND 6515-01-153-5669
TOTAL PRIMARY CONTAINER QUANTITY: 12

NDC00264-1965-10

HETASTARCH IN SODIUM CHLORIDE INJECTION

NSN, MFG P/N

6505012811247

NSN

6505-01-281-1247

View More Info

NDC00264-1965-10

HETASTARCH IN SODIUM CHLORIDE INJECTION

NSN, MFG P/N

6505012811247

NSN

6505-01-281-1247

MFG

B BRAUN MEDICAL INC WOUND CARE DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT AND 6.000 PERCENTAGE, W/V HETASTARCH ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HETASTARCH IN SODIUM CHLORIDE INJECTION 500ML BAG 12S
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG WITH HANGING DEVICE, PLASTIC
SPECIAL FEATURES: 12 OVERPOUCHES PER PACKAGE ALSO SUPPLIED TO SERVE AS A WATER VAPOR BARRIER; FOR USE WITH THE FOLLOWING NSNS' 6515-00-115-0032,6515-00-140-0888,6515-00-185-5158,6515-00-484-0484,6515-01-082-1021,6515-01-105-0614,6515-01-153-4703,AND 6515-01-153-5669
TOTAL PRIMARY CONTAINER QUANTITY: 12

NDC10019-0999-59

HETASTARCH IN SODIUM CHLORIDE INJECTION

NSN, MFG P/N

6505012811247

NSN

6505-01-281-1247

View More Info

NDC10019-0999-59

HETASTARCH IN SODIUM CHLORIDE INJECTION

NSN, MFG P/N

6505012811247

NSN

6505-01-281-1247

MFG

BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT AND 6.000 PERCENTAGE, W/V HETASTARCH ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HETASTARCH IN SODIUM CHLORIDE INJECTION 500ML BAG 12S
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG WITH HANGING DEVICE, PLASTIC
SPECIAL FEATURES: 12 OVERPOUCHES PER PACKAGE ALSO SUPPLIED TO SERVE AS A WATER VAPOR BARRIER; FOR USE WITH THE FOLLOWING NSNS' 6515-00-115-0032,6515-00-140-0888,6515-00-185-5158,6515-00-484-0484,6515-01-082-1021,6515-01-105-0614,6515-01-153-4703,AND 6515-01-153-5669
TOTAL PRIMARY CONTAINER QUANTITY: 12

BETOPIC

BETAXOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION

NSN, MFG P/N

6505012811248

NSN

6505-01-281-1248

View More Info

BETOPIC

BETAXOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION

NSN, MFG P/N

6505012811248

NSN

6505-01-281-1248

MFG

ALCON LABORATORIES INC .

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 PERCENTAGE, W/V BETAXOLOL HYDROCHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BETAXOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION 15ML
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH OPHTHALMIC TIP
SPECIAL FEATURES: ISOTONIC BUFFERED AQUEOUS SOLUTION

BETOPIC DROP-TAINER

BETAXOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION

NSN, MFG P/N

6505012811248

NSN

6505-01-281-1248

View More Info

BETOPIC DROP-TAINER

BETAXOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION

NSN, MFG P/N

6505012811248

NSN

6505-01-281-1248

MFG

ALCON LABORATORIES INC .

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 PERCENTAGE, W/V BETAXOLOL HYDROCHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BETAXOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION 15ML
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH OPHTHALMIC TIP
SPECIAL FEATURES: ISOTONIC BUFFERED AQUEOUS SOLUTION

NDC00065-0245-15

BETAXOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION

NSN, MFG P/N

6505012811248

NSN

6505-01-281-1248

View More Info

NDC00065-0245-15

BETAXOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION

NSN, MFG P/N

6505012811248

NSN

6505-01-281-1248

MFG

ALCON LABORATORIES INC .

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 PERCENTAGE, W/V BETAXOLOL HYDROCHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BETAXOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION 15ML
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH OPHTHALMIC TIP
SPECIAL FEATURES: ISOTONIC BUFFERED AQUEOUS SOLUTION

NDC61314-0245-02

BETAXOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION

NSN, MFG P/N

6505012811248

NSN

6505-01-281-1248

View More Info

NDC61314-0245-02

BETAXOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION

NSN, MFG P/N

6505012811248

NSN

6505-01-281-1248

MFG

FALCON PHARMACEUTICALS LTD

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 PERCENTAGE, W/V BETAXOLOL HYDROCHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BETAXOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION 15ML
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH OPHTHALMIC TIP
SPECIAL FEATURES: ISOTONIC BUFFERED AQUEOUS SOLUTION

NDC00006-3539-04

FAMOTIDINE INJECTION

NSN, MFG P/N

6505012811249

NSN

6505-01-281-1249

View More Info

NDC00006-3539-04

FAMOTIDINE INJECTION

NSN, MFG P/N

6505012811249

NSN

6505-01-281-1249

MFG

MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS FAMOTIDINE PER MILLILITER
ADMINISTRATION: INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FAMOTIDINE INJECTION 10MG/ML 2ML VIAL 10S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 10

PEPCID

FAMOTIDINE INJECTION

NSN, MFG P/N

6505012811249

NSN

6505-01-281-1249

View More Info

PEPCID

FAMOTIDINE INJECTION

NSN, MFG P/N

6505012811249

NSN

6505-01-281-1249

MFG

MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS FAMOTIDINE PER MILLILITER
ADMINISTRATION: INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FAMOTIDINE INJECTION 10MG/ML 2ML VIAL 10S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 10

PEPCID INJECTION

FAMOTIDINE INJECTION

NSN, MFG P/N

6505012811249

NSN

6505-01-281-1249

View More Info

PEPCID INJECTION

FAMOTIDINE INJECTION

NSN, MFG P/N

6505012811249

NSN

6505-01-281-1249

MFG

MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS FAMOTIDINE PER MILLILITER
ADMINISTRATION: INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FAMOTIDINE INJECTION 10MG/ML 2ML VIAL 10S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 10